Search and analyze individual stocks with comprehensive metrics
Astonea Labs Ltd
Fundamental Score
Astonea Labs Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ASTONEALAB across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Return on Equity (44.66%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (19.74%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Revenue Growth (40.24%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Balanced Promoter Holding (72.30%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Profit Decline Concern (-33.33%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Limited Institutional Interest (FII+DII: 2.86%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Astonea Labs Ltd
About ASTONEALAB
Business Overview
Astonea Labs Limited manufactures and markets pharmaceutical and cosmetic products under the Glow Up, Avicel, and Regero brand names in India and internationally. It offers pharmaceutical products, including generics, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as cosmetic and personal care products such as skincare, haircare, anti-aging, ethical, and organic cosmetic lines. The company offers its products in tablets, capsules, softgels, soaps, oral and external powders, ointments, aerosols, creams, and lotions, as well as toothpastes and mouthwashes. Astonea Labs Limited was incorporated in 2017 and is based in Panchkula, India.
Company Details
Key Leadership
ASTONEALAB Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Astonea Labs Ltd (ASTONEALAB)?
As of 19 Jan 2026, 10:09 am IST, Astonea Labs Ltd (ASTONEALAB) is currently trading at ₹154.00. The stock has a market capitalization of ₹157.67 (Cr).
Is ASTONEALAB share price Overvalued or Undervalued?
ASTONEALAB is currently trading at a P/E ratio of 33.98x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Astonea Labs Ltd share price?
Key factors influencing ASTONEALAB's price include its quarterly earnings growth (Sales Growth: 40.24%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Astonea Labs Ltd a good stock for long-term investment?
Astonea Labs Ltd shows a 5-year Profit Growth of N/A% and an ROE of 44.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.73 before investing.
How does Astonea Labs Ltd compare with its industry peers?
Astonea Labs Ltd competes with major peers in the Pharmaceuticals. Investors should compare ASTONEALAB's P/E of 33.98x and ROE of 44.66% against the industry averages to determine its competitive standing.
What is the P/E ratio of ASTONEALAB and what does it mean?
ASTONEALAB has a P/E ratio of 33.98x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹34 for every ₹1 of annual earnings.
How is ASTONEALAB performing according to Bull Run's analysis?
ASTONEALAB has a Bull Run fundamental score of 31.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ASTONEALAB belong to?
ASTONEALAB operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Astonea Labs Ltd.
What is Return on Equity (ROE) and why is it important for ASTONEALAB?
ASTONEALAB has an ROE of 44.66%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Astonea Labs Ltd generates profits from shareholders' equity.
How is ASTONEALAB's debt-to-equity ratio and what does it indicate?
ASTONEALAB has a debt-to-equity ratio of 0.73, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is ASTONEALAB's dividend yield and is it a good dividend stock?
ASTONEALAB offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ASTONEALAB grown over the past 5 years?
ASTONEALAB has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ASTONEALAB and why does it matter?
Promoters hold 72.30% of ASTONEALAB shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ASTONEALAB's market capitalization category?
ASTONEALAB has a market capitalization of ₹158 crores, placing it in the Small-cap category.
How volatile is ASTONEALAB stock?
ASTONEALAB has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ASTONEALAB?
ASTONEALAB has a 52-week high of ₹N/A and low of ₹N/A.
What is ASTONEALAB's operating profit margin trend?
ASTONEALAB has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ASTONEALAB's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 40.24% and YoY Profit Growth of -33.33%.
What is the institutional holding pattern in ASTONEALAB?
ASTONEALAB has FII holding of 2.51% and DII holding of 0.35%. Significant institutional holding often suggests professional confidence in the stock.